Audited standalone and consolidated Financial Results for the half year and financial year ended March 31, 2026
Audited Standalone And Consolidated Financial Results For The Half Year And Financial Year Ended March 31, 2026
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vanta Bioscience Ltd. on 6ix
Earlier from Vanta Bioscience
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2026
- Vanta Bioscience Ltd. Press Release May 26 2026
- Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Half Year And Financial Year Ended March 31, 2026 - Board Meeting To Be Held On May 30, 2026
- Vanta Bioscience Ltd. Press Release Apr 10 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Vanta Bioscience
- Closure of Trading Window
- Vanta Bioscience Ltd. Press Release Sep 29 2026
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Vanta Bioscience Ltd. Press Release Sep 30 2026
Follow Vanta Bioscience into a list and get an email when it puts out news.
Follow Vanta Bioscience